These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25810367)

  • 21. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
    Khare T; Bissonnette M; Khare S
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells.
    Heinrich EL; Lee W; Lu J; Lowy AM; Kim J
    J Transl Med; 2012 Apr; 10():68. PubMed ID: 22472349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects.
    Hattermann K; Held-Feindt J; Lucius R; Müerköster SS; Penfold ME; Schall TJ; Mentlein R
    Cancer Res; 2010 Apr; 70(8):3299-308. PubMed ID: 20388803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CXCL12-CXCR7 signaling activates ERK and Akt pathways in human choriocarcinoma cells.
    Tripathi V; Kumar R; Dinda AK; Kaur J; Luthra K
    Cell Commun Adhes; 2014 Aug; 21(4):221-8. PubMed ID: 24450273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a chimeric chemokine as a specific ligand for ACKR3.
    Ameti R; Melgrati S; Radice E; Cameroni E; Hub E; Thelen S; Rot A; Thelen M
    J Leukoc Biol; 2018 Aug; 104(2):391-400. PubMed ID: 29601107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma.
    Liberman J; Sartelet H; Flahaut M; Mühlethaler-Mottet A; Coulon A; Nyalendo C; Vassal G; Joseph JM; Gross N
    PLoS One; 2012; 7(8):e43665. PubMed ID: 22916293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The chemokine receptors CXCR4/CXCR7 and their primary heterodimeric ligands CXCL12 and CXCL12/high mobility group box 1 in pancreatic cancer growth and development: finding flow.
    Shakir M; Tang D; Zeh HJ; Tang SW; Anderson CJ; Bahary N; Lotze MT
    Pancreas; 2015 May; 44(4):528-34. PubMed ID: 25872129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of the chemokines I-TAC (CXCL11) and SDF-1 (CXCL12) in the regulation of tumor angiogenesis of colorectal cancer.
    Rupertus K; Sinistra J; Scheuer C; Nickels RM; Schilling MK; Menger MD; Kollmar O
    Clin Exp Metastasis; 2014 Apr; 31(4):447-59. PubMed ID: 24493023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the chemokine CXCL12 and combined internalization of its receptors CXCR4 and CXCR7 in human MCF-7 breast cancer cells.
    Hattermann K; Holzenburg E; Hans F; Lucius R; Held-Feindt J; Mentlein R
    Cell Tissue Res; 2014 Jul; 357(1):253-66. PubMed ID: 24770893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overlapping and distinct role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 axes in regulating metastatic behavior of human rhabdomyosarcomas.
    Grymula K; Tarnowski M; Wysoczynski M; Drukala J; Barr FG; Ratajczak J; Kucia M; Ratajczak MZ
    Int J Cancer; 2010 Dec; 127(11):2554-68. PubMed ID: 20162608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging roles of atypical chemokine receptor 3 (ACKR3) in normal development and physiology.
    Quinn KE; Mackie DI; Caron KM
    Cytokine; 2018 Sep; 109():17-23. PubMed ID: 29903572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feedback control of the CXCR7/CXCL11 chemokine axis by estrogen receptor α in ovarian cancer.
    Benhadjeba S; Edjekouane L; Sauvé K; Carmona E; Tremblay A
    Mol Oncol; 2018 Oct; 12(10):1689-1705. PubMed ID: 30051594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CXCR7 controls competition for recruitment of β-arrestin 2 in cells expressing both CXCR4 and CXCR7.
    Coggins NL; Trakimas D; Chang SL; Ehrlich A; Ray P; Luker KE; Linderman JJ; Luker GD
    PLoS One; 2014; 9(6):e98328. PubMed ID: 24896823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the new CXCL12 receptor, CXCR7, in gliomas.
    Calatozzolo C; Canazza A; Pollo B; Di Pierro E; Ciusani E; Maderna E; Salce E; Sponza V; Frigerio S; Di Meco F; Schinelli S; Salmaggi A
    Cancer Biol Ther; 2011 Jan; 11(2):242-53. PubMed ID: 21084856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
    Nazari A; Khorramdelazad H; Hassanshahi G
    Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effects of CXCR4-CXCL12- and CXCR7-CXCL12-mediated immune reactions on murine P0106-125 -induced experimental autoimmune neuritis.
    Brunn A; Utermöhlen O; Mihelcic M; Sánchez-Ruiz M; Carstov M; Blau T; Ustinova I; Penfold M; Montesinos-Rongen M; Deckert M
    Neuropathol Appl Neurobiol; 2013 Dec; 39(7):772-87. PubMed ID: 23452257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C-X-C motif chemokine ligand 12 (CXCL12)/C-X-C motif chemokine receptor 7(CXCR7) regulates epithelial-mesenchymal transition process and promotes the metastasis of esophageal cancer by activating signal transducer and activator of transcription 3 (STAT3) pathway.
    Guo J; Tong CY; Shi JG; Li XJ
    Bioengineered; 2022 Mar; 13(3):7425-7438. PubMed ID: 35264069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bilayer lipids modulate ligand binding to atypical chemokine receptor 3.
    Eberle SA; Gustavsson M
    Structure; 2024 Aug; 32(8):1174-1183.e5. PubMed ID: 38776922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The chemokine receptor CXCR7 is expressed on lymphatic endothelial cells during renal allograft rejection.
    Neusser MA; Kraus AK; Regele H; Cohen CD; Fehr T; Kerjaschki D; Wüthrich RP; Penfold ME; Schall T; Segerer S
    Kidney Int; 2010 May; 77(9):801-8. PubMed ID: 20164826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.